申请人:The Regents of the University of California
公开号:US04942173A1
公开(公告)日:1990-07-17
The present invention relates to a compound of the formula (I): ##STR1## wherein R is C.sub.2-10 alkyl, alkenyl or alkynyl, each optionally substituted by or methyl substituted by cyano, C.sub.3-4 cycloalkyl, halo, C.sub.1-4 alkoxy or a group S(O)m R.sup.4 where R.sup.4 is C.sub.1-4 alkyl and m is 0, 1 or 2, or Ris C.sub.3-10 cycloalkyl, C.sub.4-10 cycloalkenyl or phenyl, each optionally substituted by C.sub.1-4 alkoxy, C.sub.1-3 alkyl, C.sub.2-4 alkynyl, halo, cyano or a group S(O)m R.sup.4 as defined hereinbefore; R.sup.1 is halo, C.sub.1-3 alkyl, C.sub.2-3 alkenyl or alkynyl each optionally substituted by halo, cyano, C.sub.1-4 alkoxy, alkyl carbalkoxy containing up to 6 carbon atoms, a group S(O)m R.sup.4 as defined hereinbefore or alkynyl substituted by tri-C.sub.1-4 alkylsilyl, or R.sup.1 is cyano, spiro-cyclopropyl, gem dimethyl, gem dicyano, gem diethynyl, oxo or methylene optionally substituted by cyano of C.sub.1-3 alkyl optionally substituted by fluorine, or R.sup.1 and R and the carbon atoms to which they are attached form a C.sub.5-7 carbocyclic ring optionally substituted by halo, C.sub.1-3 alkyl or alkoxy or C.sub.2-3 alkenyl, R.sup.2 is phenyl substituted by an C.sub.2-3 alkynyl group or by a tri-C.sub.1-4 alkylsilylalkynyl group and R.sup.3 is hydrogen, C.sub.1-3 alkyl, C.sub.2-3 alkenyl or alkynyl each optionally substituted by cyano, C.sub.1-4 alkylthio, C.sub.1-4 alkoxy or halo, or R.sup.3 is cyano or halo, its use in medicine, pharmaceutical compositions containing it and its preparation.
本发明涉及一种式(I)的化合物:##STR1## 其中R是C.sub.2-10烷基,烯基或炔基,每个可选择地由氰基取代或由C.sub.3-4环烷基,卤素,C.sub.1-4烷氧基或S(O)mR.sup.4基团取代,其中R.sup.4是C.sub.1-4烷基,m为0、1或2,或者R为C.sub.3-10环烷基,C.sub.4-10环烯基或苯基,每个可选择地由C.sub.1-4烷氧基,C.sub.1-3烷基,C.sub.2-4炔基,卤素,氰基或如上所定义的S(O)mR.sup.4基团取代;R.sup.1是卤素,C.sub.1-3烷基,C.sub.2-3烯基或炔基,每个可选择地由卤素,氰基,C.sub.1-4烷氧基,含有最多6个碳原子的烷基羰基甲基,如上所定义的S(O)mR.sup.4基团或炔基取代的三C.sub.1-4烷基硅基,或者R.sup.1是氰基,螺环丙基,双甲基,双氰基,双乙炔基,氧代或由C.sub.1-3烷基选择性取代的亚甲基,该C.sub.1-3烷基可选择性地由氟取代,或者R.sup.1和R以及它们所连接的碳原子形成C.sub.5-7环烷基,每个可选择地由卤素,C.sub.1-3烷基或烷氧基或C.sub.2-3烯基取代,R.sup.2是由C.sub.2-3炔基或三C.sub.1-4烷基硅基炔基取代的苯基,R.sup.3是氢,C.sub.1-3烷基,C.sub.2-3烯基或炔基,每个可选择地由氰基,C.sub.1-4烷硫基,C.sub.1-4烷氧基或卤素取代,或者R.sup.3是氰基或卤素,其在医药中的应用,含有它的制药组合物及其制备。